Introduction: Hyperuricaemia is frequently associated with type 2 diabetes and contributes to increased morbidity and mortality, particularly cardiovascular and renal. The aim of this study was to investigate the prevalence of hyperuricaemia and associated factors in patients with type 2 diabetes monitored at the Abass Ndao Hospital Centre in Dakar. Materials and Methods: This was a retrospective descriptive and analytical study conducted over a one-year period, from 1 January to 31 December 2022. Data were collected from the medical records of type 2 diabetic patients who had undergone uric acid testing. Statistical analysis was performed using Epi Info 2000 software version 3.3.2. Results: Hyperuricaemia was found in 66 patients, representing a prevalence of 16.7%, with a male/female ratio of 0.5. The average age was 60.6 ± 9.7 years. The average duration of diabetes was 10.5 ± 8.4 years. Hypertension was associated in 57.6% of hyperuricaemic cases compared with 41.6% in non-hyperuricaemic cases (p = 0.017). Renal impairment (22.7%) and anaemia (29.5%) were significantly more common in hyperuricaemic patients. Gout was found in 6% of patients. Conclusion: Hyperuricaemia is relatively common in patients with type 2 diabetes and is associated with several cardiometabolic and renal risk factors. Systematic screening and integrated management could help reduce morbidity and mortality in diabetic patients.
References
[1]
International Diabetes Federation (2023) IDF Diabetes Atlas. 11th Edition, International Diabetes Federation.
[2]
Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030. Diabetes Care, 27, 1047-1053. https://doi.org/10.2337/diacare.27.5.1047
[3]
Dehghan, A., van Hoek, M., Sijbrands, E.J.G., Hofman, A. and Witteman, J.C.M. (2008) High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes. DiabetesCare, 31, 361-362. https://doi.org/10.2337/dc07-1276
[4]
Johnson, R.J., Nakagawa, T., Sanchez-Lozada, L.G., Shafiu, M., Sundaram, S., Le, M., et al. (2013) Sugar, Uric Acid, and the Etiology of Diabetes and Obesity. Diabetes, 62, 3307-3315. https://doi.org/10.2337/db12-1814
[5]
Nakagawa, T., Kang, D.H., Feig, D., Sanchez-Lozada, L.G., Srinivas, T.R., Sautin, Y., et al. (2006) Unearthing Uric Acid: An Ancient Factor with Recently Found Significance in Renal and Cardiovascular Disease. KidneyInternational, 69, 1722-1725. https://doi.org/10.1038/sj.ki.5000391
[6]
Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., et al. (2009) Association between Serum Uric Acid and Development of Type 2 Diabetes. DiabetesCare, 32, 1737-1742. https://doi.org/10.2337/dc09-0288
[7]
Ogbera, A.O. and Azenabor, A.O. (2015) Hyperuricemia and Metabolic Syndrome in Patients with Type 2 Diabetes in Nigeria. African Journal of Medicine and Medical Sciences, 44, 113-120.
[8]
El Aziz, S., El Ghomari, H., El Ansari, N., et al. (2018) Hyperuricemia and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes Mellitus in Morocco. Pan African Medical Journal, 31, Article 187.
[9]
International Diabetes Federation (2012) Global Guideline for Type 2 Diabetes. IDF.
[10]
American Diabetes Association (2022) Standards of Medical Care in Diabetes-2022. Diabetes Care, 45, S1-S264.
[11]
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. EuropeanHeartJournal, 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
[12]
Cole, T.J., Bellizzi, M.C., Flegal, K.M. and Dietz, W.H. (2000) Establishing a Standard Definition for Child Overweight and Obesity Worldwide: International Survey. BMJ, 320, 1240-1240. https://doi.org/10.1136/bmj.320.7244.1240
[13]
International Diabetes Federation (2005) The IDF Consensus Worldwide Definition of the Metabolic Syndrome. IDF.
[14]
Damoune, I., Lahlou, A., El Ouahabi, H., Ajdi, F., Sy, O. and Nejjari, C. (2014) P232 Acide urique et diabète type 2. Diabetes&Metabolism, 40, A83. https://doi.org/10.1016/s1262-3636(14)72523-6
[15]
Wanvoegbe, K.A., Agbodande, A., Alassani, J., et al. (2017) Hyperuricemia in Patients with Type 2 Diabetes in Cotonou: Prevalence and Associated Factors. Journal of the Society of Clinical Biology of Benin, 27, 5-9.
[16]
Habak, N., Rouibah, N. and Chikouche, A. (2022) Prevalence of Hyperuricaemia in Type 2 Diabetics. Journal algérien de biochimie et de génétique médicales, 2.
[17]
Oulad Sayad, N., Ridouane, S., Diouri, A. and Ridouane, S. (2008) P137 Diabète du sujet âgé. Diabetes & Metabolism, 34, H80. https://doi.org/10.1016/s1262-3636(08)73049-0
[18]
Sereni, S., Delgado, H., et al. (2000) Glycaemic Control in Type 2 Diabetics. Revue Médicale Suisse, 4, 205-209.
[19]
Choi, H.K. and Ford, E.S. (2008) Haemoglobin A1c, Fasting Glucose, Serum C-Peptide and Insulin Resistance in Relation to Serum Uric Acid Levels—The Third National Health and Nutrition Examination Survey. Rheumatology, 47, 713-717. https://doi.org/10.1093/rheumatology/ken066
[20]
Iguchi, M., Umekawa, T., Takamura, C., Sugihara, I., Nakamura, K., Kohri, K., et al. (1993) Glucose Metabolism in Renal Stone Patients. UrologiaInternationalis, 51, 185-190. https://doi.org/10.1159/000282542
[21]
Zerifi, R., Bahlous, A., Marakchi, O., et al. (2008) Metabolic Syndrome: Pathophysiology and Impact on Lithogenesis. Annales de Biologie Clinique, 66, 9-17.
[22]
Cheng, W., Wen, S., Wang, Y., Qian, Z., Tan, Y., Li, H., et al. (2017) The Association between Serum Uric Acid and Blood Pressure in Different Age Groups in a Healthy Chinese Cohort. Medicine, 96, e8953. https://doi.org/10.1097/md.0000000000008953
[23]
Deléaval, P. and Burnier, M. (2005) L’hyperuricémie dans l’hypertension artérielle: Quelle implication? RevueMédicaleSuisse, 1, 2072-2079. https://doi.org/10.53738/revmed.2005.1.32.2072
[24]
Fagot-Campagna, A., Fosse, S., Roudier, C., et al. (2009) Characteristics, Vascular Risk and Complications in People with Diabetes in France: Changes between ENTRED 2001 and 2007. Weekly Epidemiological Bulletin, 2009, 42-43.
[25]
Benghezel, H., Cheribet, A., Bezzouza, H., Khelifi, I., Alloui, N., Bencherif, R., et al. (2019) Hyperuricemia and Cardiovascular Risk: Study in a Population Admitted to the Cardiology Department of the University Hospital of Batna. Batna Journal ofMedicalSciences (BJMS), 6, 109-115. https://doi.org/10.48087/bjmsoa.2019.6206
[26]
Woyesa, S.B., Hirigo, A.T. and Wube, T.B. (2017) Hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients at Hawassa University Comprehensive Specialized Hospital, South West Ethiopia. BMCEndocrineDisorders, 17, Article No. 76. https://doi.org/10.1186/s12902-017-0226-y
[27]
Schlienger, J.L. (2016) Hyperuricémie chronique: Facteur ou marqueur de risque cardio-métabolique? MédecinedesMaladiesMétaboliques, 10, 280-284. https://doi.org/10.1016/s1957-2557(16)30070-0
[28]
Traxer, O., Lechevallier, E., Saussine, C., Daudon, M. and Haymann, J. (2008) Syndrome métabolique et lithiase urinaire. Une notion nouvelle pour l’urologue. Progrès en Urologie, 18, 828-831. https://doi.org/10.1016/j.purol.2008.09.033
[29]
Weiner, D.E., Tighiouart, H., Elsayed, E.F., Griffith, J.L., Salem, D.N. and Levey, A.S. (2008) Uric Acid and Incident Kidney Disease in the Community. Journal of the AmericanSocietyofNephrology, 19, 1204-1211. https://doi.org/10.1681/asn.2007101075
[30]
Li, M., Hou, W., Zhang, X., Hu, L. and Tang, Z. (2014) Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-Analysis of Prospective Studies. Atherosclerosis, 232, 265-270. https://doi.org/10.1016/j.atherosclerosis.2013.11.051
[31]
Amani, K. and Amani, M.E.A. (2009) P256 Anémie chez le diabétique: Quelles particularités? Diabetes & Metabolism, 35, A87. https://doi.org/10.1016/s1262-3636(09)72054-3
[32]
Chales, G. (2011) From hyperuricaemia to gout: Epidemiology of gout. Revue du rhumatisme, 78, S109-S115.
